Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review-Reference-Cited by-同舟云学术

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Author:

De Hert M.¹,Peuskens J.¹,Sabbe T.¹,Mitchell A. J.²,Stubbs B.³,Neven P.⁴,Wildiers H.⁴⁵,Detraux J.¹

Affiliation:

1. Department of Neurosciences; KU Leuven University Psychiatric Centre; Kortenberg Belgium

2. Department of Psycho-oncology, Cancer & Molecular Medicine; University of Leicester; Leicester UK

3. School of Health and Social Care; University of Greenwich; Greenwich UK

4. Multidisciplinary Breast Center; University Hospitals Leuven; KU Leuven - University of Leuven; Leuven Belgium

5. Department of General Medical Oncology; Leuven Cancer Institute; University Hospitals Leuven; KU Leuven - University of Leuven; Leuven Belgium

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

Reference224 articles.

1. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review;Peuskens;CNS Drugs,2014

3. Focus on prolactin as a metabolic hormone;Ben-Jonathan;Trends Endocrinol Metab,2006

5. Mammary gland development;Macias;Wiley Interdiscip Rev Dev Biol,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献